Advisory Board Co. (NASDAQ: ABCO) was downgraded to Underperform from Buy and the price objective was lowered to $36 from $48 at Merrill Lynch.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was downgraded to Neutral from Overweight and the price target was cut to $84 from $105 (versus an $82.00 close) at Piper Jaffray.
Cerner Corp. (NASDAQ: CERN) was downgraded to Underperform from Neutral at Merrill Lynch, with the price objective reduced to $51 from $60.
Extraction Oil & Gas LLC (NYSE: XOG) saw its quiet period come to an end and shares closed at $20.42. It was started as Sector Perform with a $24 price target, and Citigroup started it as Neutral. Wells Fargo started it as Outperform, while Barclays started it as Overweight with a $24 price target. KeyBanc started the stock as Overweight with a $25 price target. Credit Suisse started it as Outperform with a $30 target price.
Fairmount Santrol Holdings Inc. (NYSE: FMSA) was raised to Outperform from Neutral at Credit Suisse.
Impax Laboratories Inc. (NASDAQ: IPXL) was downgraded to Underperform from Neutral at Merrill Lynch.
L Brands Inc. (NYSE: LB) was downgraded to Underperform at Jefferies, and the price target was cut to $50 from $70 (versus a $65.00 close).
SteadyMed Ltd. (NASDAQ: STDY) was started as Buy with a $10 price target (versus a $3.90 close) at H.C. Wainwright.
Timken Co. (NYSE: TKR) was raised to Buy from Hold with a $37 price target (versus a $32.30 close) at Evercore ISI.
VimpelCom Ltd. (NYSE: VIP) was started as Outperform at Credit Suisse.
Last week brought five key oil and gas stocks analysts want you to buy.
There were also seven stocks under $10 with big upside.
Analysts have five out-of-favor stocks yielding 5% or more.
Fridays’ top analyst upgrades and downgrades included Agrium, Array BioPharma, Encana, GoPro, 3D Systems and over a dozen more.